New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Qiagen N.V.
QGEN
Shape
US Flag

NYSE

10B

Medical - Diagnostics & Research

Next Earning date - 06 Nov 2024

10B

Medical - Diagnostics & Research

Next Earning date - 06 Nov 2024

43.92USD
Shape0.64 ( 1.48%)
favorite-chart

Relative Strenght

25
favorite-chart

Volume Buzz

-60%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

7%

Quote Panel

Shape
Updated October 12, 2024
1W 1.39 % 1M -5.26 % 3M 5.07 % 1Y 17.75 %

Key Metrics

Shape
  • Market Cap

    9.74B


  • Shares Outstanding

    221.85M


  • Share in Float

    221.24M


  • Dividende

    1.31959


  • Earning Date

    06 Nov 2024


  • Price Target

    43.92


  • Average Volume

    1.28M


  • Beta

    0.388


  • Range

    34.74-47.44


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.qiagen.com


  • Sector

    Healthcare


Fundamentals

Shape

21.12x

P/E Ratio

5.02x

P/S Ratio

2.86x

P/B Ratio

0.4

Debt/Equity

3.7%

Net Margin

$0.3

EPS

How QGEN compares to sector?

P/E Ratio

Relative Strength

Shape

QGEN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape322%

2025-Revenue

$2.00

Shape341%

2025-EPS

$799M

Shape354%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wolfe Research

upgrade

Previous: Not converted

2024-06-27

Now: Outperform

Morgan Stanley

upgrade

Previous: Not converted

2024-02-16

Now: Overweight

Goldman Sachs

upgrade

Previous: Not converted

2023-12-07

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-5%

0.55
vs 0.58

Q4.22

arrow
arrow

-26%

0.55
vs 0.74

Q1.23

arrow
arrow

-34%

0.53
vs 0.8

Q2.23

arrow
arrow

+4%

0.53
vs 0.51

Q3.23

arrow
arrow

-5%

0.52
vs 0.55

Q4.23

arrow
arrow

N/A

0.55
vs 0.55

Q1.24

arrow
arrow

-13%

0.46
vs 0.53

Q2.24

arrow
arrow

+4%

0.55
vs 0.53

Q3.24

arrow
arrow

+5%

0.54
vs 0.52

Q4.24

arrow
arrow

+9%

0.6
vs 0.55

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-7%

499.6M  vs 534.7M

Q4.22

arrow
arrow

-14%

498M  vs 582.4M

Q1.23

arrow
arrow

-23%

485.4M  vs 628.4M

Q2.23

arrow
arrow

-4%

494.9M  vs 515.5M

Q3.23

arrow
arrow

-5%

475.9M  vs 499.6M

Q4.23

arrow
arrow

+2%

509.2M  vs 498M

Q1.24

arrow
arrow

-5%

458.8M  vs 485.4M

Q2.24

arrow
arrow

+0%

496.3M  vs 494.9M

Q3.24

arrow
arrow

+3%

491.2M  vs 475.9M

Q4.24

arrow
arrow

+3%

524.5M  vs 509.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+2%

0.02
vs 0.03

Q4.22

arrow
arrow

+3%

0.03
vs 0.02

Q1.23

arrow
arrow

+2%

0.02
vs 0.03

Q2.23

arrow
arrow

+2%

0.02
vs 0.02

Q3.23

arrow
arrow

+2%

0.02
vs 0.02

Q4.23

arrow
arrow

+3%

0.03
vs 0.02

Q1.24

arrow
arrow

+2%

0.02
vs 0.03

Q2.24

arrow
arrow

-5%

-0.05
vs 0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

304

304
vs 290

5%

Q4.22

arrow
arrow

307

307
vs 304

1%

Q1.23

arrow
arrow

291

291
vs 307

-5%

Q2.23

arrow
arrow

287

287
vs 291

-1%

Q3.23

arrow
arrow

285

285
vs 287

-1%

Q4.23

arrow
arrow

273

273
vs 285

-4%

Q1.24

arrow
arrow

293

293
vs 273

7%

Q2.24

arrow
arrow

318

318
vs 293

9%

Earnings Growth

Latest News